ShadowBuys
Sign inJoin for free
Committee overlap: Finance

Sen. Ron Wyden sold Pfizer (PFE)

Sen. Ron Wyden (D-OR) · $1K–$15K · traded Jun 3, 2025

Why this is a committee overlap

Wyden is the Ranking Member of the Senate Committee on Finance, which oversees Drug Manufacturers companies. Pfizer is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$1K–$15K
Owner
Spouse
Traded
Jun 3, 2025
Disclosed
Jul 2, 2025
Days to disclose
29
Asset type
Stock
As filed
Pfizer, Inc. Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Wyden's tradesAll Congress trades in PFE

Recent Congress trades in PFE

Company context for PFE

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. PFECompany announcement·SEC EDGAR

    PFE: Leadership change

    Filed 8-K for an event or period dated 2026-10-30. Leadership change.

    Public: Nov 3, 2026, 4:19 PM ESTEvent / period: Oct 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. PFEFinancial report·SEC EDGAR

    PFE: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.

    Public: Nov 3, 2026, 8:19 AM ESTEvent / period: Sep 27, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. PFECompany announcement·SEC EDGAR

    PFE: Financial results

    Filed 8-K for an event or period dated 2026-11-03. Financial results.

    Public: Nov 3, 2026, 8:07 AM ESTEvent / period: Nov 3, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.